Ramesh Akkina

Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.

John J Rossi, Shirley Li, John Zaia, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy

D. Kaufman, R. Akkina, Ramesh Akkina, 2006, Retrovirology.

New generation humanized mice for virus research: comparative aspects and future prospects.

R. Akkina, Ramesh Akkina, 2013, Virology.

Identification of Novel Influenza A Virus Proteins Translated from PA mRNA

Takeshi Noda, Yukiko Muramoto, Yoshihiro Kawaoka, 2012, Journal of Virology.

CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection

R. Akkina, Joseph Anderson, Ramesh Akkina, 2005, Retrovirology.

Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells

John J. Rossi, Jiehua Zhou, J. Rossi, 2009, Nucleic acids research.

Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.

Ling Peng, David D Smith, John J Rossi, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.

John Rossi, J. Rossi, Ming-jie Li, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.